PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

MD Anderson researchers identify a rescuer for vital tumor-suppressor

Enzyme intervenes when cancer-fighting PTEN is bound for cell's protein-destroying machinery

2013-11-27
(Press-News.org) Contact information: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
MD Anderson researchers identify a rescuer for vital tumor-suppressor Enzyme intervenes when cancer-fighting PTEN is bound for cell's protein-destroying machinery HOUSTON – A protector for PTEN, a tumor-thwarting protein often missing in cancer cells, has emerged from research led by scientists at The University of Texas MD Anderson Cancer Center published online at Nature Cell Biology this week.

"We discovered that the enzyme USP13 stabilizes the PTEN protein by reversing a process that marks various proteins for destruction by the cell's proteasome," said the paper's senior author Li Ma, Ph.D., assistant professor of Experimental Radiation Oncology.

"USP13 also suppresses tumor formation and glycolysis though PTEN," Ma said. Glycolysis is a glucose metabolism pathway that tumors rely on to thrive and grow.

After establishing the relationship in cell lines and mouse model experiments, the team found low levels of USP13 in human breast tumors correlate with lower levels of PTEN. Both proteins were more abundantly present in normal breast tissue.

PTEN regulates cell growth and division. It also inhibits signaling by the AKT molecular pathway, which is involved in cell survival, metabolism and growth and is often overactive in human cancers.

This discovery provides a new way to think about PTEN deficiency and how it might be remedied. Ma noted the likely keys to possible treatment would be identifying druggable oncogenes that suppress USP13 in cancer cells, or hitting targets usually controlled by PTEN.

"In our paper, we showed that loss of USP13 leads to loss of PTEN and activation of AKT signaling, and that treatment of a breast cancer cell line with the AKT inhibitor MK-2206 can abolish the effect of USP13 loss on promoting tumor cell proliferation," Ma said. MK-2206 is actively being tested in clinical trials against a variety of cancers at MD Anderson and elsewhere, including advanced breast cancer.

Genetic defects alone don't explain PTEN's absence

"The rationale of our work is that despite the frequent genetic alterations seen in the PTEN gene in human cancer, loss of the PTEN protein has been observed in a much higher percentage of human tumors," Ma said. "For example, approximately 5 percent of non-inherited breast tumors carry PTEN gene mutations, but loss of the PTEN protein is actually reported in nearly 40 percent of breast tumors."

This suggested, Ma said, that regulation of PTEN after gene expression or after its translation into a protein "may contribute substantially to development of human breast cancer."

Ma and colleagues focused on ubiquitylation, a process that regulates proteins by attaching molecules called ubiquitins to them. When more than one ubiquitin is attached to a protein, a chain forms that is both a target and a handle for the proteasome – a protein complex that degrades proteins and recycles bits of them for other use.

Previous studies had revealed several proteins that attach ubiquitins to PTEN to initiate its destruction. Nothing had been identified that reverses that process for PTEN.

Auditioning 30 DUBs to find one PTEN defender

The team screened 30 known deubiquitylating enzymes (DUBs). Of those, USP13 was noteworthy for its ability to stabilize PTEN by directly binding to it and removing ubiquitins. A series of experiments showed that overexpressing USP13 in breast cancer cells:

Increased PTEN expression and decreased cell multiplication and conversion to a cancerous state. Reduced cancer-promoting AKT signaling. Had no effect in cancer cells that lacked the PTEN gene.

The team also confirmed that USP13 removes ubiquitins from PTEN. Silencing USP13 expression tripled the polyubiquitylation of PTEN, expressing USP13 reduced it by 65 percent.

Knocking down USP13 in breast cancer cells increased cell multiplication and growth, while restoring either PTEN or USP13 completely reversed the effect.

Lower USP13, larger tumors in mice

In mice, those implanted with a breast cancer cell line with USP13 depleted had a 2.5-fold increase in tumor volume and a 3.5-fold increase in tumor weight over 65 days compared with a control group.

Ma and colleagues also analyzed USP13 and PTEN using human breast cancer progression tissue microarrays from the National Cancer Institute.

Lower PTEN levels were found in 152 of 206 tumors (73.8 percent) and lower USP13 levels in 83 of 201 (41.3 percent). Of the 83 tumors with low USP13, 73 (88 percent) also had low PTEN. In normal breast tissue, only 31.8 percent had low levels of PTEN; 13.2 percent had low USP13.

"Our future studies aim to determine the physiological function of USP13 and how USP13 expression is lost in human cancer," Ma said.

### Co-authors with Ma are first author Jinsong Zhang, Ph.D., Peijing Zhang, Ph.D., Hai-long Piao, Ph.D., Wenqi Wang, Ph.D., Min Wang, Dahu Chen, Ph.D. and Junjie Chen, Ph.D., of MD Anderson's Department of Experimental Radiation Oncology; Yongkun Wei, Ph.D., Yutong Sun, Ph.D., and Mien-Chie Hung, Ph.D., of MD Anderson's Department of Molecular and Cellular Oncology; and Subbareddy Maddika, Ph.D., of the Laboratory of Cell Death and Cell Survival, Centre for DNA Fingerprinting and Diagnostics, Nampally, Hyderabad, India.

Grants from the National Cancer Institute of the U.S. National Institutes of Health (R00CA138572 and R01CA166051) and a Cancer Prevention and Research Institute of Texas Scholar Award to Ma funded this research. MD Anderson receives a cancer center support grant from the NCI (P30 CA016672).

About MD Anderson

The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. MD Anderson is one of only 41 comprehensive cancer centers designated by the National Cancer Institute. For 10 of the past 12 years, including 2013, MD Anderson has ranked No. 1 in cancer care in "Best Hospitals," a survey published annually in U.S. News & World Report. MD Anderson receives a cancer center support grant from the National Cancer Institute of the National Institutes of Health (P30 CA016672). Get MD Anderson News Via RSS Follow MD Anderson News on Twitter


ELSE PRESS RELEASES FROM THIS DATE:

NASA watches as India braces for Tropical Cyclone Lehar

2013-11-27
NASA watches as India braces for Tropical Cyclone Lehar Tropical Cyclone Lehar is weakening as it heads for a landfall in eastern India. NASA's Aqua satellite captured an image of the storm nearing the coast today, November 27. Warnings were in effect in India ...

Flexible, stretchable fire-ant rafts

2013-11-27
Flexible, stretchable fire-ant rafts How ants form structure to protect against raindrops and waves described at upcoming APS Division of Fluid Dynamics Meeting ...

Better combustion through plasma

2013-11-27
Better combustion through plasma Plasma-assisted combustion could help make jets fly higher, faster and longer, according to work presented at APS Division of Fluid Dynamics Meeting WASHINGTON D.C. Nov. 26, 2013 -- Mix together air, fuel, and heat and you ...

Interaction of nurses, pharmacists, and other non-physician clinicians within pharmaceutical industry is common

2013-11-27
Interaction of nurses, pharmacists, and other non-physician clinicians within pharmaceutical industry is common Scrutiny of physician relationships with industry has culminated in passage of the US Physician Payments Sunshine Act (part of the Affordable Care Act), intended ...

New therapeutic target identified for Huntington's disease

2013-11-27
New therapeutic target identified for Huntington's disease A new study published 26th November in the open access journal PLOS Biology, identifies a new target in the search for therapeutic interventions for Huntington's disease – a devastating late-onset neurodegenerative ...

Scientists characterize effects of transplanted fecal microbiota

2013-11-27
Scientists characterize effects of transplanted fecal microbiota Longitudinal study examines patients treated for recurrent Clostridium difficile infections Baltimore, Md. — November 26, 2013 -- Scientists at the Institute for Genome Sciences at ...

2009 pandemic flu death toll much higher than official worldwide estimates

2013-11-27
2009 pandemic flu death toll much higher than official worldwide estimates WASHINGTON, DC (Nov. 26, 2013)—A research team consisting of more than 60 collaborators in 26 countries has estimated the global death ...

Micronutrient supplements reduce risk of HIV disease progression and illness

2013-11-27
Micronutrient supplements reduce risk of HIV disease progression and illness Long-term (24-month) supplementation with multivitamins plus selenium for human immunodeficiency virus (HIV)-infected patients in Botswana in the early stages of disease who had ...

Drug improves remission of Crohn disease among children and adolescents

2013-11-27
Drug improves remission of Crohn disease among children and adolescents Among children and adolescents with Crohn disease not responding to treatment, use of the drug thalidomide resulted in improved clinical remission after 8 weeks of treatment compared ...

Study finds no increased risk of retinal detachment with use of certain antibiotics

2013-11-27
Study finds no increased risk of retinal detachment with use of certain antibiotics In contrast to findings of a recent study, researchers in Denmark did not find an association between use of a class of antibiotics known as fluoroquinolones (such as ciprofloxacin) ...

LAST 30 PRESS RELEASES:

A map for single-atom catalysts

What about tritiated water release from Fukushima? Ocean model simulations provide an objective scientific knowledge on the long-term tritium distribution

Growing crisis of communicable disease in Canada in tandem with US cuts

Women get better at managing their anger as they age

Illegal shark product trade evident in Australia and New Zealand

New search tool brings 21% better accuracy for robotics developers

New model extracts sentence-level proof to verify events, boosting fact-checking accuracy for journalists, legal teams, and policymakers

Efficient carbon integration of CO₂ in propane aromatization over acidic zeolites

FPGA-accelerated AI for demultiplexing multimode fiber towards next-generation communications

Vitamin D3 nanoemulsion significantly improves core symptoms in children with autism: A clinical trial

Microfluidic point-of-care device accurately measures bilirubin in blood serum: A pilot study

Amygdalin shows strong binding and stabilizing effects on HER2 receptor: A computational study for breast cancer therapy

Bond behavior of FRP bars in concrete under reversed cyclic loading: an experimental study

Milky Way-like galaxy M83 consumes high-speed clouds

Study: What we learned from record-breaking 2021 heat wave and what we can expect in the future

Transforming treatment outcomes for people with OCD

Damage from smoke and respiratory viruses mitigated in mice via a common signaling pathway

New software tool could help better understand childhood cancer

Healthy lifestyle linked to lower diverticulitis risk, irrespective of genetic susceptibility

Women 65+ still at heightened risk of cervical cancer caused by HPV

‘Inflammatory’ diet during pregnancy may raise child’s diabetes type 1 risk

Effective therapies needed to halt rise in eco-anxiety, says psychology professor

Nature-friendly farming boosts biodiversity and yields but may require new subsidies

Against the odds: Endometriosis linked to four times higher pregnancy rates than other causes of infertility, new study reveals

Microplastics discovered in human reproductive fluids, new study reveals

Family ties and firm performance: How cousin marriage traditions shape informal businesses in Africa

Novel flu vaccine adjuvant improves protection against influenza viruses, study finds

Manipulation of light at the nanoscale helps advance biosensing

New mechanism discovered in ovarian cancer peritoneal metastasis: YWHAB restriction drives stemness and chemoresistance

New study links blood metabolites and immune cells to increased risk of urolithiasis

[Press-News.org] MD Anderson researchers identify a rescuer for vital tumor-suppressor
Enzyme intervenes when cancer-fighting PTEN is bound for cell's protein-destroying machinery